Douglas Goldman

752 total citations
30 papers, 335 citations indexed

About

Douglas Goldman is a scholar working on Psychiatry and Mental health, Molecular Biology and Neurology. According to data from OpenAlex, Douglas Goldman has authored 30 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Douglas Goldman's work include Electroconvulsive Therapy Studies (6 papers), Schizophrenia research and treatment (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Douglas Goldman is often cited by papers focused on Electroconvulsive Therapy Studies (6 papers), Schizophrenia research and treatment (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Douglas Goldman collaborates with scholars based in United States, United Kingdom and Denmark. Douglas Goldman's co-authors include Jerrold I. Davis, Lynn G. Clark, Melvin R. Duvall, Chelsea D. Specht, Christopher R. Hardy, John V. Freudenstein, Lisa M. Campbell, Michael F. Fay, Dennis Wm. Stevenson and Chris Pires and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Annals of the New York Academy of Sciences.

In The Last Decade

Douglas Goldman

28 papers receiving 260 citations

Peers

Douglas Goldman

PMH

EEBS

PHARM

D. N. Love United Kingdom

Andrea Baker Australia

Patricia Roberts United States

CHARLES E. DE LA VEGA Canada

S Puźyński Poland

M Kurcz Hungary

Chiung-Chih Chang Taiwan

Jus A France

J. Walden Germany

E Friedel Germany

D. N. Love United Kingdom

Douglas Goldman

41 ×0.4

PMH

47 ×0.5

20 ×0.3

EEBS

22 ×0.6

7 ×0.2

PHARM

Citations per year, relative to Douglas Goldman Douglas Goldman (= 1×) peers D. N. Love

Countries citing papers authored by Douglas Goldman

Since Specialization

Citations

This map shows the geographic impact of Douglas Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Goldman more than expected).

Fields of papers citing papers by Douglas Goldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Goldman. The network helps show where Douglas Goldman may publish in the future.

Co-authorship network of co-authors of Douglas Goldman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Goldman. A scholar is included among the top collaborators of Douglas Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Goldman. Douglas Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seberg, Ole, Jerrold I. Davis, Douglas Goldman, et al.. (2006). Mitochondrial Data in Monocot Phylologenetics. Aliso. 22(1). 52–62. 27 indexed citations

Belfer, Inna, Steven A. Atlas, Tianxia Wu, et al.. (2005). Correlation between the polymorphisms in galanin receptor 3 gene and chronic pain in patients with post-diskectomy sciatica. Journal of Pain. 6(3). S9–S9.

Goldman, Douglas, et al.. (2000). The New Drugs (Chlorpromazine & Reserpine): Administrative Aspects. Psychiatric Services. 51(3). 327–331. 3 indexed citations

Marks, Gerald S., et al.. (1986). The effects of dihydropyridine calcium antagonists on heme biosynthesis in chick embryo liver cell culture. Canadian Journal of Physiology and Pharmacology. 64(4). 438–443. 6 indexed citations

Goldman, Douglas. (1977). The Scientific Study of Marihuana. American Journal of Psychiatry. 134(7). 832–833. 1 indexed citations

Goldman, Douglas. (1976). Drugs in Combination with Other Therapies. American Journal of Psychiatry. 133(12). 1482–a. 39 indexed citations

Goldman, Douglas. (1970). Treatment of Barbiturate Dependence. JAMA. 213(13). 2272–2272. 1 indexed citations

Goldman, Douglas. (1965). Elektroencephalographische studien bei endogenen psychosen und deren behandlung mit psychotropen medikamenten unter besonderer berücksichtigung des pentothal-elektroencephalogramms. Electroencephalography and Clinical Neurophysiology. 19(4). 426–427. 5 indexed citations

Goldman, Douglas, et al.. (1964). THE EFFECT OF CHLORDIAZEPOXIDE ON CONVULSIVE DISORDER.. PubMed. 25. 52–8. 1 indexed citations

10.

Goldman, Douglas. (1964). Electroencephalographic manifestations associated with psychotic illness: Pentothal activation technique and pharmacologic interrelationships. Comprehensive Psychiatry. 5(2). 80–92. 4 indexed citations

11.

Goldman, Douglas. (1961). The barbiturate withdrawal syndrome. Electroencephalography and Clinical Neurophysiology. 13(1). 151–151. 15 indexed citations

12.

Goldman, Douglas. (1961). Parkinsonism and related phenomena from administration of drugs: their production and control under clinical conditions and possible relation to therapeutic effect.. PubMed. 20. 549–60. 25 indexed citations

13.

Goldman, Douglas. (1961). Psychodynamic Observations in Psychopharmacology. Psychosomatics. 2(5). 379–381. 1 indexed citations

14.

Goldman, Douglas. (1959). CLINICAL EXPERIENCE WITH NEWER ANTIDEPRESSANT DRUGS AND SOME RELATED ELECTROENCEPHALOGRAPHIC OBSERVATIONS. Annals of the New York Academy of Sciences. 80(3). 687–704. 12 indexed citations

15.

Goldman, Douglas. (1959). Specific electroencephalographic changes with pentothal activation in psychotic states. Electroencephalography and Clinical Neurophysiology. 11(4). 657–667. 14 indexed citations

16.

Goldman, Douglas. (1957). COMPARISON OF CLINICAL EFFECTS OF CHLORPROMAZINE AND RESERPINE IN PSYCHOTIC PATIENTS. The American Journal of the Medical Sciences. 233(2). 137–144. 4 indexed citations

17.

Goldman, Douglas. (1956). The major complications of treatment of psychotic states with chlorpromazine and reserpine and their management.. PubMed. 79–88. 10 indexed citations

18.

Goldman, Douglas. (1955). TREATMENT OF PSYCHOTIC STATES WITH CHLORPROMAZINE. Journal of the American Medical Association. 157(15). 1274–1274. 45 indexed citations

19.

Goldman, Douglas. (1955). Agranulocytosis Associated with Administration of Chlorpromazine. A M A Archives of Internal Medicine. 96(4). 496–496. 8 indexed citations

20.

Goldman, Douglas. (1952). NEW TREATMENT FOR HEREDITARY (HUNTINGTON) CHOREA. The American Journal of the Medical Sciences. 224(5). 573–576. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact